Ron de Jong
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 4
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 8
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer 7
- Protein Degradation and Inhibitors 3
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 7
- Oncology top 10%
-
- Microtubule and mitosis dynamics 5
-
- Cancer Mechanisms and Therapy 4
-
- Quinazolinone synthesis and applications 3
- Co-authors
- John GroffenNora HeisterkampJohanna ten HoeveMorris J. BirnbaumTilman OltersdorfHan ChoMark S. FormanDiana W. Shineman
- Journals
- Bioorganic & Medicinal Chemistry Letters (6 papers)Journal of Biological Chemistry (5 papers)Molecular Cancer Therapeutics (3 papers)
- Partner nations
- United StatesJapanNetherlands
In The Last Decade
Ron de Jong
30 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 97
- Immunology and Allergy 128
- Hematology 224
- Molecular Biology 1.1k
- Genetics 164
- Oncology 289
Countries citing papers authored by Ron de Jong
This map shows the geographic impact of Ron de Jong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron de Jong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron de Jong more than expected).
Fields of papers citing papers by Ron de Jong
This network shows the impact of papers produced by Ron de Jong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron de Jong. The network helps show where Ron de Jong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ron de Jong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 0 | |
| 2 | 2019 | 3 | |
| 3 | 2018 | 30 | |
| 4 | 2017 | 11 | |
| 5 | 2017 | 12 | |
| 6 | 2013 | 34 | |
| 7 | 2013 | 28 | |
| 8 | 2010 | 47 | |
| 9 | 2010 | 213 | |
| 10 | 2006 | 42 | |
| 11 | 2006 | 31 | |
| 12 | 2002 | 23 | |
| 13 | Crkl enhances leukemogenesis in BCR/ABL P190 transgenic mice. | 2001 | 38 |
| 14 | 1999 | 1 | |
| 15 | 1998 | 29 | |
| 16 | 1997 | 75 | |
| 17 | 1995 | 113 | |
| 18 | 1993 | 48 | |
| 19 | 1993 | 36 | |
| 20 | 1992 | 2 |
About Ron de Jong
Ron de Jong is a scholar working on Hematology, Immunology and Allergy, Genetics, Cell Biology and Oncology, having authored 33 papers that have together received 1.6k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), Microtubule and mitosis dynamics (5 papers), Cancer Mechanisms and Therapy (4 papers), Cell Adhesion Molecules Research (4 papers), Quinazolinone synthesis and applications (3 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Immunology and Allergy (128 citations), Hematology (224 citations), Molecular Biology (1.1k citations), Genetics (164 citations) and Oncology (289 citations). Ron de Jong has collaborated with scholars based in United States, Japan and Netherlands. Frequent co-authors include John Groffen, Nora Heisterkamp, Johanna ten Hoeve, Morris J. Birnbaum, Tilman Oltersdorf, Han Cho, Mark S. Forman, Diana W. Shineman, Matthias Szabolcs and Virginia M.‐Y. Lee. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry, Molecular Cancer Therapeutics, Oncogene and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.